Protokinetix Stock Current Liabilities
| PKTX Stock | USD 0.01 0 10.64% |
Protokinetix fundamentals help investors to digest information that contributes to Protokinetix's financial success or failures. It also enables traders to predict the movement of Protokinetix Pink Sheet. The fundamental analysis module provides a way to measure Protokinetix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Protokinetix pink sheet.
Protokinetix |
Protokinetix Company Current Liabilities Analysis
Protokinetix's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Protokinetix Current Liabilities | 40 K |
Most of Protokinetix's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Protokinetix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Protokinetix has a Current Liabilities of 40 K. This is 100.0% lower than that of the Healthcare sector and 99.99% lower than that of the Biotechnology industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Protokinetix Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Protokinetix's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Protokinetix could also be used in its relative valuation, which is a method of valuing Protokinetix by comparing valuation metrics of similar companies.Protokinetix is currently under evaluation in current liabilities category among its peers.
Protokinetix Fundamentals
| Return On Equity | -4.03 | |||
| Return On Asset | -2.22 | |||
| Current Valuation | 7.5 M | |||
| Shares Outstanding | 316.85 M | |||
| Shares Owned By Insiders | 30.73 % | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Earning | (9.86) X | |||
| Price To Book | 20.13 X | |||
| EBITDA | (2.33 M) | |||
| Net Income | (2.33 M) | |||
| Cash And Equivalents | 18.83 K | |||
| Debt To Equity | 31.50 % | |||
| Current Ratio | 0.54 X | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (889.89 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 0.13 | |||
| Market Capitalization | 9.51 M | |||
| Total Asset | 446.23 K | |||
| Retained Earnings | (28.25 M) | |||
| Working Capital | 140 K | |||
| Current Asset | 180 K | |||
| Current Liabilities | 40 K | |||
| Net Asset | 446.23 K |
About Protokinetix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Protokinetix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Protokinetix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Protokinetix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Protokinetix Pink Sheet Analysis
When running Protokinetix's price analysis, check to measure Protokinetix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protokinetix is operating at the current time. Most of Protokinetix's value examination focuses on studying past and present price action to predict the probability of Protokinetix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protokinetix's price. Additionally, you may evaluate how the addition of Protokinetix to your portfolios can decrease your overall portfolio volatility.